Applied BioCode Corporation EPS (Diluted) for the year ending December 31, 2024: USD -0.09

Applied BioCode Corporation EPS (Diluted) is USD -0.09 for the year ending December 31, 2024, a 33.96% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • Applied BioCode Corporation EPS (Diluted) for the year ending December 31, 2023 was USD -0.07, a -11.19% change year over year.
  • Applied BioCode Corporation EPS (Diluted) for the year ending December 31, 2022 was USD -0.07, a 1.17% change year over year.
  • Applied BioCode Corporation EPS (Diluted) for the year ending December 31, 2021 was USD -0.07, a 54.11% change year over year.
  • Applied BioCode Corporation EPS (Diluted) for the year ending December 31, 2020 was USD -0.05, a -67.56% change year over year.
Key Data
Date EPS (Diluted) Shares (Diluted, Weighted) Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses